637 related articles for article (PubMed ID: 12843962)
1. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
3. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
Balfour Sartor R
J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
[TBL] [Abstract][Full Text] [Related]
4. The genetics of inflammatory bowel disease.
Bonen DK; Cho JH
Gastroenterology; 2003 Feb; 124(2):521-36. PubMed ID: 12557156
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in the handling of intracellular bacteria in Crohn's disease: a link between infectious etiology and host genetic susceptibility.
Glasser AL; Darfeuille-Michaud A
Arch Immunol Ther Exp (Warsz); 2008; 56(4):237-44. PubMed ID: 18726145
[TBL] [Abstract][Full Text] [Related]
6. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
Caprilli R; Frieri G
Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
[TBL] [Abstract][Full Text] [Related]
7. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
8. Defects in mucosal immunity leading to Crohn's disease.
Cobrin GM; Abreu MT
Immunol Rev; 2005 Aug; 206():277-95. PubMed ID: 16048555
[TBL] [Abstract][Full Text] [Related]
9. Bacterial flora in inflammatory bowel disease.
Marteau P
Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
[TBL] [Abstract][Full Text] [Related]
10. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
Agius LM
J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
[TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
12. Adherent-invasive Escherichia coli and Crohn's disease.
Barnich N; Darfeuille-Michaud A
Curr Opin Gastroenterol; 2007 Jan; 23(1):16-20. PubMed ID: 17133079
[TBL] [Abstract][Full Text] [Related]
13. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
14. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
[TBL] [Abstract][Full Text] [Related]
15. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor RB
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
[TBL] [Abstract][Full Text] [Related]
17. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.
Sheikh S; Uno J; Matsuoka K; Plevy S
Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
Fiocchi C
Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
[TBL] [Abstract][Full Text] [Related]
19. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
Sartor RB
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
